Other
Neuromodulation
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Neuromodulation is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
7
clinical trials
Unknown status2 · 29%
Recruiting1 · 14%
Terminated1 · 14%
Suspended1 · 14%
Withdrawn1 · 14%
Completed1 · 14%
Clinical Trials
Trial Activity
7 trials
Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With SCI Treated With EES
Completed·—·Phase 1·NCT04052776·3 enrolled
Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder Syndrome
Unknown status·FFundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia·Phase 4·NCT03468465·110 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)